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ABSTRACT 
Background: 
Invasive non-Typhi Salmonella (NTS) infection is endemic in sub-Saharan Africa where 
it is the leading cause of blood stream infection. Host risk factors such as HIV infection, 
malaria and /or anemia, recent antimicrobial use, malnutrition, extreme ages, sickle cell 
disease and schistosomiasis have been reported in some studies. However, little 
information is available about environmental reservoir. Since a systematic review had 
not been done to assess if NTS infection is more likely to occur in persons with named 
risk factors compared to those without risk factors, preventive strategies are 
underdeveloped. 
  
Objective: 
The primary objective of this paper is to review the literature systematically and answer 
the questions whether NTS infection is associated with any of the following: HIV 
infection, malaria, recent antimicrobial use, anemia, sickle cell, schistosomiasis, 
malnutrition and extreme ages. The role of environment in the spread of NTS infection 
will also be explored. 
 
Methods: 
The systematic review was conducted by searching MEDLINE including the clinical 
queries option through December 2008 for English language articles containing the 
MESH phrases (Salmonella) NOT (Salmonella Typhi) NOT (Salmonella Enteric serovar) 
AND (Africa) OR (Sub-Saharan Africa).The articles that could not be retrieved from the 
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Medline were obtained from the CDC library. The search was also expanded using cited 
references from the articles obtained in the initial search. 
 
Results: 
Of 571 articles obtained, 93 were reviewed to yield 6 articles to find an association 
between NTS and the named risk factors. Moreover 9 articles explore the role of 
environment reservoir.NTS infection was significantly associated with HIV infection OR= 
3.21(95%CI 1.95-5.28), severe malnutrition OR= 2.2 (95%CI) and malaria OR=1.6. NTS 
infection was common in patients with sickle cell disease, schistosomiasis, extreme age 
and those with history of recent antimicrobial use but lacked statistical significance. 
Seasonal peaks of NTS disease occur during the rainy season among both adults and 
children suggesting environmental risk factors are important. 
 
Conclusions: 
Invasive NTS infection was associated HIV, Severe malnutrition and Malaria in Sub 
Saharan Africa. Because of the substantial burden of illness and death caused by 
invasive NTS disease, it is important to utilize these associations in developing 
preventive strategies to control invasive NTS infection in Sub Saharan Africa. 
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 Glossary of terms 
1.NTS = Non- Typhi Salmonella 
2.Bacteremia = Bacteria in the blood stream 
3.Osteomyelitis = Infection of the bone or bone marrow. Usually caused by pyogenic 
bacteria or mycobacteria 
4.Pathogens = Disease causing organisms 
5.Zoonotic = Animal diseases which can be transmitted to human such as rabies etc. 
7.Nosocomial = Hospital acquired infections 
8.Achlorydia = Absence or low production of gastric acid 
9.Hemolysis = Destruction of red blood cells 
10.Phagocytic cells = Cells that are responsible for engulfing and destroying foreign 
bodies 
11.Siderophilic organisms = Iron loving organisms. They live by oxidizing iron. 
12.Schistosomiasis= also known as bilharziasis or snail fever, is a primarily tropical 
parasitic disease caused by the larvae of one or more of five types of flatworms or blood 
flukes known as schistosomes 
13.Splenomegaly = Enlarged spleen 
14.In vitro = Technique of performing a procedure under controlled environment outside 
the organisms 
15.In vivo = Technique of performing a procedure inside an organism 
16.Virulence = Ability of the organism to infect another organism 
17.SXT = Antibacterial combination of trimethoprim and sulphamethaxazole 
18.Recrudescence = Reappearance of disease after it has been quiescent 
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1. INTRODUCTION 
Salmonella enterica subspecies enterica includes over 2,400 serotypes found in 
humans and other warm-blooded animals. Non-Typhi Salmonella enterica serotypes are 
abbreviated using their serotype name, for example Salmonella Typhimurium [1].  
Non-Typhi Salmonella (NTS) is among the three most common pathogens causing 
bacterial bloodstream infections in adults and children in sub-Saharan Africa [2-9].  HIV-
infected adults and children <3 years of age carry most of the burden of invasive 
disease and mortality in these groups is high.  This contrasts to the developed world, 
where NTS disease is usually a self-limited colitis, and mortality is low, even in 
immunosuppressed, young or elderly, bacteremic patients. 
 
2. METHODS OF SYTEMATIC REVIEW 
2.1 Focused questions 
 A systematic review of the literature relative to NTS was carried out to address the 
following focused questions: 
 Is the Invasive NTS more likely to occur in HIV infected patients than in 
uninfected persons? 
 Is the Invasive NTS more likely to occur in people with Malaria and/or Anemia 
than those without Malaria and or Anemia? 
 Is the invasive NTS more likely to occur in malnourished children than in those 
who are well nourished? 
 Is Invasive NTS infection more likely to occur in people with recent history of 
antimicrobial than in those without recent history of antimicrobial use? 
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 Is Invasive NTS more likely to occur in people with extreme ages (<5 years and 
elders) than others? 
 Is Invasive NTS more likely to occur in patients with sickle cell than in those 
without sickle cell disease? 
 Is invasive NTS more likely to occur in patients with schistosomiasis than in 
those without schistosomiasis? 
 What is the role of environment with regard to invasive NTS infection? 
 
2.2. Data sources and search strategy 
Utilizing the outline in Figure 1, the following data sources and search strategy was 
used. To identify relevant articles, a MEDLINE electronic database search using 
PubMed, was perfomed to explore the articles published from 1986 through 2008.The 
search was done in the English language. The following  medical headings (MeSH) and 
key words were used in the search strategy: (Salmonella) NOT (Salmonella typhi )NOT 
(Salmonella enteric serovar) AND( Africa )OR (Sub-Saharan Africa).Specific terms used 
under overall search were bacteremia,sepsis,septicemia,fever,antimicrobial drug 
resistance,therapeutics,treatment,therapy,prophylaxis,epidemics,riskfactors,malaria,HIV
,environmental microbiology,water,water microbiology, water supply, prevention & 
control,prevention,primary prevention, guidelines , Health planning guidelines, practice 
guidelines , standards and guidelines. The articles that could not be retrieved from 
Medline were obtained from CDC library. The search process was then expanded by 
identifying additional articles from cited references in articles obtained in the initial 
search. The abstracts of these articles were examined with respect to inclusion criteria. 
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2.3. Inclusion criteria 
The following were used as inclusion criteria: 
 Publications from peer reviewed journals. 
 Presentation and analysis of Non salmonella data from Africa and some other 
parts of developed world. 
The abstracts of selected articles were reviewed to assess those which met eligibility 
criteria. The quality of each study was assessed using Oxford Centre for Evidence 
Based Medicine Levels of Evidence (May 2001 Version).Quality ratings of studies are 
shown (see table 1). 
 
3. BURDEN OF DISEASE 
Invasive NTS disease is endemic in sub-Saharan Africa, in both rural and urban areas. 
The burden of mortality from childhood invasive bacterial disease in sub-Saharan Africa 
is probably greater than that of malaria in many communities [5]. In rural Kenya, the 
estimated minimum incidence of bacteremia was 505 per 100,000 person-years in the 
under 5-years age group, of which 88 per 100,000 person-years was NTS bacteremia. 
In rural Mozambique childhood bacteremia incidence was 425 per 100,000 person-
years in children <15 years of age, of which NTS incidence was 120/100,000 person-
years [9]. The true incidence of bacteremia is likely to be 2-3 times this figure, as 
bacteremia among children dying before reaching the district hospital was unable to be 
ascertained in either study [5, 9]. While studying the impact of the conjugate 
pneumococcal vaccine in the Gambia, Enwere et al demonstrated an incidence of NTS 
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bacteremia of 262 per 100,000 person-years among children aged ≤ 29 months not 
vaccinated with the pneumococcal vaccine [6]. In Uganda, NTS bacteremia was 
reported to be rare among adults with CD4-positive T-lymphocyte counts (CD4 counts) 
above 500 cells/mm3, but 500 per 100,000 per year among adults with CD4 counts 200 
to 500 cells/mm3, and 7,500 per 100,000 per year among adults with CD4 counts < 200 
cells/mm3 [10]. Case fatality estimates for invasive NTS disease in Africa have ranged 
between 4.4% and 27% in children [6, 11-13] and between 22 and 47% in adults [8, 14]. 
Case fatality in meningitis may be higher with NTS than for any other common cause of 
bacterial meningitis. For example, in Malawi 64% of neonates with NTS meningitis died 
compared to 26% for group B Streptococcus meningitis [4]. While these studies provide 
some insight into the burden of invasive NTS disease for Africa, none are population-
based and most have focused on high risk groups such as young children and HIV-
infected adults. The actual incidence is likely to vary by population HIV prevalence, local 
conditions and age distribution. It is likely that the incidence of invasive NTS disease in 
sub-Saharan Africa is higher than for typhoid fever, which has been estimated to occur 
with an incidence of 50 per 100,000 per year in Africa [15]. Furthermore, hospital-based 
studies suggest that typhoid fever may be considerably less common than invasive NTS 
in sub-Saharan Africa [16]. 
Data on the frequency of complications of NTS bacteremia in Africa are limited. 
Meningitis, septic arthritis and osteomyelitis are described [3, 11, 17, 18], especially 
among children, where NTS may be more common than Staphylococcus aureus as a 
cause of septic arthritis [19]. Gordon et al investigated 100 adults in Malawi, 99% of 
whom were HIV-infected, with NTS bacteremia for focal suppurative disease and did not 
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identify any localized NTS infections at initial presentation [14]. Of 2,517 pediatric 
patients with NTS bacteremia in Blantyre, Malawi over 1998-2004, 85% were <36 
months old and 19-35% were estimated to be HIV-infected [8]. During the same period 
2,439 adults with NTS bacteremia were identified and approximately 95-98% of these 
patients were HIV-infected. A South African autopsy study of 50 patients who died with 
a pre-mortem clinical diagnosis of tuberculosis revealed that 94% were HIV-infected 
and 23% of these patients were harboring splenic NTS [20].  
 
4.0. RISK FACTORS AND PREVENTION STRATEGIES 
Risk factors for NTS infection in Africa have not been well characterized; consequently 
evidence-based prevention interventions are limited. Small African studies and 
evidence-based prevention studies for NTS in more developed countries may provide 
clues until more data from Africa are available. Prospective studies of enteric NTS 
infection that investigate risk factors for development of bacteremia are limited.  A North 
American study noted a bacteremia incidence of 6% among infants with NTS diarrhea, 
but modifiable risk factors were not identified [21]. 
 
4.1. Environmental risk factors 
4.1.1. Food and Water 
 Seasonal peaks of NTS disease occur with the rainy season among both adults and 
children [4, 8, 11, 22] suggesting that environmental risk factors are important. Fecal 
organisms are found at highest concentrations in drinking water sources in Africa at the 
onset of the wet season [23] and this may correspond with increased risk of waterborne 
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NTS. Protection of source water, increased access to central safe water, safe water 
storage in the home [24], and improved water quality at the household level are likely to 
reduce exposure to NTS and to other enteric pathogens [25]. Strategies such as use of 
narrow-mouthed, spigoted containers for water storage [26] and treatment of water at 
home by chlorination, solar disinfection, filtration, flocculation, or a combination of 
measures have been shown to reduce the risk for diarrhea [27]. Numerous outbreaks of 
food-borne illness due to NTS have been studied in industrialized countries and such 
outbreaks have also been described in Africa. Meat, eggs, produce, and dairy products 
have all been implicated as vehicles for transmission. NTS infect or colonize most 
mammalian species. Food animals such as chickens have been a focus of efforts to 
reduce transmission of NTS disease to humans in developed countries [28]. NTS have 
also been isolated from cattle, goats, sheep and pigs in African slaughterhouses. 
Identification and management of hazards facilitated by microbiological sampling at 
critical control points from farm to fork have been utilized in developing as well as 
industrialized countries to improve food safety and to control NTS [29].  
 
4.1.2. Zoonotic and anthroponotic transmission 
 Animal contact, particularly handling of young chickens by children, is a well-
established risk factor for acquisition of NTS disease in industrialized countries [30].  
While not often considered a common risk factor for NTS infection in developed world 
studies, anthroponotic transmission has been suggested as being relatively more 
important in Africa [22, 31]. Kariuki et al demonstrated carriage of identical strains of 
NTS in the stool of human household contacts of pediatric cases of invasive disease, 
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and a lack of such strains from environmental and domestic animal sampling from the 
households, although a common source from food or water could not be ruled out [22]. 
Asymptomatic carriers of NTS have been demonstrated in Africa [32]. A Kenyan study 
of NTS carriage at admission to hospital found that 20 (3.6%) of 556 children were 
carriers but none of 111 adults carried NTS [33]. Asymptomatic carriers of NTS have 
also been described in more developed countries, where it is known that children are 
likely to excrete NTS in their stool for some weeks after recovering from enteric 
infection.  
 
4.1.3. Nosocomial transmission 
Outbreaks of NTS have been described in hospitals in many parts of the world, 
occurring among patients admitted with a different diagnosis. Nosocomial outbreaks can 
be particularly severe on pediatric wards in developing countries where children may be 
malnourished and have other host risk factors. Transmission may be person-to-person, 
or from contaminated food. High case fatality is frequently observed especially when 
such outbreaks are caused by strains of NTS resistant to the local empiric therapy [18]. 
Ten percent of 360 adult and pediatric patients with nosocomial diarrhea occurring in a 
Kenyan hospital in 1988 were due to Salmonella. Among children recent antimicrobial 
use, age 6 months to 6 years, and crowded living conditions at home were associated 
with nosocomial diarrhea due to Salmonella.  Among adults, sharing a hospital room 
with somebody with diarrhea and a history of previous hospitalization were associated 
with nosocomial Salmonella diarrhea [33]. Prevention strategies could include patient 
and visitor education regarding personal hygiene and food preparation and storage (in 
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African hospitals food is usually provided by a patient’s family), provision of safe 
drinking water, hand washing before and after patient contact by healthcare workers, 
thorough cleaning of the hospital environment, reduction in crowding, avoiding sharing 
beds between children, increasing the number of healthcare workers, adequate 
disinfection of reusable equipment, and surveillance for NTS infections and isolation of 
identified cases [18, 34].  
 
4.2. Host risk factors 
4.2.1. Age 
 Children and infants under the age of 3 years are particularly at risk for invasive NTS 
disease. Infants have less well developed immune systems and relative gastric 
achlorydia compared with adults [6]. Endovascular infections with NTS are described in 
adults >50 years of age in the industrialized world. Older age may also be a risk factor 
in African populations, but is dominated by HIV-associated NTS disease among 
younger adults. 
 
4.2.2. Exposure to antimicrobials 
Recent use of antimicrobial agents, is an established risk factor for development of NTS 
gastrointestinal infection [35]. Among children in a Kenyan hospital in 1988, recent 
antimicrobial use was associated with nosocomial diarrhea due to Salmonella [33]. Prior 
antimicrobial use and malnutrition contribute to abnormal gastrointestinal flora with 
possible loss of mucosal integrity. Use of an antimicrobial agent to which circulating 
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NTS are resistant could select for more resistant strains as well as interrupting the 
protective effect of normal intestinal flora. 
 
4.2.3. Malaria and anemia  
Malaria has long been suspected to increase the risk of invasive NTS infection and may 
contribute to the seasonality of NTS disease. While the mechanism underlying the 
association between malaria and NTS is only partially understood, malarial hemolysis 
may lead to impaired macrophage and neutrophil function due to the accumulation of 
malarial pigment by phagocytic cells, saturation of iron-binding proteins, and increased 
iron availability to NTS, a siderophilic organism. While some studies have shown an 
association between malaria and NTS bacteremia [6], others have demonstrated an 
association between recent malaria or malarial anemia and NTS compared to other 
causes of bacteremia [3, 11, 36]. Thus measures directed at malaria control may have 
the potential to lead to reduction in invasive NTS disease in tropical Africa. 
 
4.2.4. Malnutrition  
Malnutrition was associated with NTS bacteremia among children in Kilifi, Kenya [5, 11]. 
Malnutrition, measles and diarrheal disease were common reasons for admission 
among children who subsequently developed nosocomial NTS disease in Rwanda [18]. 
While children < 3 years of age are at greater risk for NTS disease, those < 4 months 
old appear to be relatively protected, perhaps both by maternal antibody [37] and 
exclusive breast-feeding which provides colostrum and limits exposure to unsafe water 
and food.  
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4.2.5. HIV  
NTS bacteremia is more common among HIV-infected individuals [2] and the 
association with HIV infection is strongest among adults. Recurrent NTS bacteremia is a 
WHO Stage 4 defining condition for patients with HIV. Prophylactic trimethoprim-
sulfamethoxazole (SXT) is recommended to prevent the occurrence of opportunistic 
infections among HIV-infected patients in Africa [38]. This strategy appears to remain 
effective, even in areas with high levels of resistance to SXT among pathogens such as 
NTS [39]. Combination antiretroviral therapy has been associated with dramatic 
reductions in the incidence of NTS enteritis and NTS bacteremia among HIV-infected 
persons in the developed world [40].  HIV infection is also a risk factor for bacteremia 
among children, including NTS bacteremia. HIV was associated with any bacteremia 
among children in Kilifi, Kenya, OR 3.22 (95% CI 2.34–4.44) and with NTS bacteremia, 
OR 3.21 (95% CI 1.95-5.28) [5].  
 
4.2.6. Gastric acid suppression 
 Use of medications that reduce gastric acidity is associated with increased risk of 
gastrointestinal infection [41]. 
 
4.2.7. Sickle Cell Disease 
 Persons homozygous for sickle cell disease are particularly at risk for bacterial sepsis, 
including NTS bacteremia. Among 78 consecutive cases of acute osteomyelitis 
complicating sickle cell disease in Nigeria, with a mean age of 12 years (range 9 
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months – 50 years), 32 were able to have cultures of blood or pus performed and half 
the cases were due to Salmonella [17].  
 
4.2.8. Schistosomiasis 
 Intestinal schistosomiasis may be a risk factor for acquisition of invasive NTS disease 
among older children in endemic regions [42]. However, among HIV-infected adults in 
Malawi, the presence of intestinal helminths was not shown to be associated with NTS 
bacteremia [43].  
 
5. CLINICAL PRESENTATION AND DIAGNOSIS 
Fever or sweats were noted among 95% of 100 Malawian adults and splenomegaly 
among 38% at initial presentation with NTS bacteremia, features suggestive of malaria 
in Africa. The median (range) hemoglobin in this 99% HIV-infected group was 6.8g/dL 
(2.5 – 11.7g/dL) [14]. Fever and splenomegaly predicted NTS bacteremia among 
hospitalized adults in Malawi [7]. In Tanzania, patients admitted to hospital for 
antimalarial treatment were more likely to die if their malaria slide was negative than if it 
was positive [44], suggesting that a lack of capacity to diagnose and treat other causes 
of fever such as bacterial sepsis may contribute to outcome. Among 166 children with 
NTS bacteremia in Kilifi, Kenya, splenomegaly was present in 44% of cases, fever in 
94% [11]. In the same rural district, 26% of all inpatient childhood deaths were 
associated with bacteremia whereas 22% of such deaths were associated with malaria. 
Of patients dying with malaria, 21% were also bacteremic [5].  
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NTS bacteremia frequently occurs without gastrointestinal symptoms in adults [14] and 
children [11]. Peters et al have noted that while adult patients with pneumococcal or 
mycobacterial sepsis could often be diagnosed clinically prior to blood culture results 
becoming available, patients with NTS sepsis were much more difficult to diagnose on 
clinical grounds due to nonspecific symptoms and signs [7]. The syndrome of childhood 
pneumonia overlaps with both malaria and NTS sepsis [3, 11, 18]. Because clinical 
diagnosis of NTS bacteremia is difficult, blood culture facilities are needed to diagnose 
invasive NTS and to conduct accurate surveillance to guide public health policy. 
Unfortunately adequate clinical laboratory infrastructure is frequently lacking in 
resource-poor countries in sub-Saharan Africa [45]. 
Outcomes were studied among Malawian adults with NTS bacteremia, 99% of whom 
were HIV-infected. Among 100 adults, 47% died within one month, 77% died within a 
year of their index presentation, and 43% of initial survivors developed at least one 
recurrence of NTS bacteremia. Molecular testing revealed that recurrence was due to 
recrudescence rather than reinfection in most instances [14]. Recrudescence probably 
occurs due to persistence of NTS intracellularly in the reticuloendothelial system. 
 
6. CLINICAL MANAGEMENT 
Empiric treatment of childhood sepsis according to World Health Organization (WHO) 
guidelines [46] with penicillin and chloramphenicol or ampicillin and gentamicin does not 
provide adequate cover for NTS disease that is resistant to ampicillin, SXT, and 
chloramphenicol. Gentamicin has limited activity for intracellular pathogens, so even 
though isolates may appear susceptible in vitro, the drug cannot be relied upon in vivo. 
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WHO guidelines advise that where there is known substantial antimicrobial resistance to 
traditional first-line antimicrobials, use of a third-generation cephalosporin may be 
appropriate [46]. The CSF penetration of ceftriaxone makes it a good choice for 
meningitis. A recent report on pediatric NTS meningitis from Malawi over 1997-2006 
demonstrated a static case fatality rate of approximately 50% but a fall in permanent 
sequelae over time, possibly associated with a change in duration of therapy from two 
to four weeks [47]. CDC recommends ciprofloxacin for the treatment of NTS bacteremia 
in HIV-infected adults and adolescents, for 4-6 weeks if the CD4 count is 
<200cells/mm3, followed by long-term secondary prophylaxis [48]. Data to guide 
duration of therapy or secondary prophylaxis for neonates, meningitis cases and HIV-
infected persons in Africa is lacking. S. Typhi with decreased ciprofloxacin susceptibility, 
often associated with nalidixic acid resistance, may not respond adequately to 
ciprofloxacin therapy. It is not known whether this is also true for NTS [49]. When 
patients with NTS bacteremia do not respond to appropriate antimicrobial therapy a 
search for focal disease and for schistosomiasis co-infection is warranted. 
 
7. MICROBIOLOGY 
S. Typhimurium and S. Enteritidis are the most common serotypes of NTS causing 
human disease in sub-Saharan Africa [8, 11, 13, 31, 37, 50]. The acquisition of a 
plasmid conveying a multidrug resistant (MDR) phenotype may be associated with 
successful spread as has been observed with S. Typhimurium in Malawi [8]. S. Isangi 
was a rare serotype in South Africa until 2002 when it expanded to account for 20% of 
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NTS isolates from national surveillance and was found to produce an extended-
spectrum β-lactamase (ESBL) [51].  
Antimicrobial resistance of NTS to SXT, ampicillin and chloramphenicol has become 
common in sub-Saharan Africa limiting the value of these agents for management of 
invasive NTS [4, 6, 8, 18].  
 
8. NTS VACCINE PROSPECTS 
Virulence of NTS is dependent on ability to grow within macrophages of the 
reticuloendothelial system [52].  Extracellular replication and bacteremic dissemination 
also occurs. Resistance to complement killing, by way of long chain lipopolysaccharide, 
is an important virulence trait.  Both complement and specific antibody together are 
required to kill Salmonella in vitro. While healthy African adult serum was able to kill 
NTS, serum from children <16 months of age often did not contain sufficient specific 
antibody titres to kill effectively [37]. This probably explains the predisposition of young 
children to invasive NTS disease and may go some way towards understanding a 
mechanism by which the immune dysregulation of HIV infection contributes to NTS 
disease risk.  Such immunologic clues suggest that vaccine development directed 
towards the common invasive serotypes could be a useful approach to control invasive 
NTS disease.  
 
9. DISCUSSION 
The systematic review represent a novel attempt to rigorously assess the link between 
Invasive non-Typhi salmonella infection and HIV,malaria,severe malnutrition,recent 
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microbial use,schistosoma and sickle cell disease in Sub-saharan Africa.Lack of 
evidence in both quality and quantity failed to demonstrate outstanding association 
between schistosoma,sickle cell,age,recent antimicrobial use and invasive NTS 
infection.Our results however showed convicing association between HIV,severe 
malnutrition, malaria and invasive NTS infection. 
There were notable studies that did not meet eligibility criteria (lack of rigor to be 
conclusive),but the trend of these studies is consistent with the findings of those studies 
which met criteria. 
 
9.1. HIV infection and Invasive NTS infection 
Two studies [5,40] have addressed the relationship between HIV and NTS 
bacteremia.Berkley AJ et al demonstrated that HIV infection is the risk factor for any 
bacteremia among children,including Invasive NTS infection. More specifically they 
showed that HIV infection was associated with invasive NTS infection among children in 
Kilifi Kenya, OR 3.22 (95% CI 2.34-4.44).An indirect association between HIV infection 
and NTS infection was shown by Hung CC et al[40].In this study they showed that the 
incidence of Invasive NTS infection was reduced among HIV infected patients receiving 
anti retroviral therapy. The mechanism of the association between HIV infection and 
NTS infection is clearly understood. HIV infection reduces individual immunity against 
infection and therefore keeps the person at risk of acquiring infection including but not 
limited to invasive NTS infection. Although the association between HIV infection and 
invasive NTS infection was demonstrated in cross sectional epidemiologic surveys, the 
measurements of infections were done by state of the art equipments. In addition, HIV 
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was a recognized risk factor of Invasive NTS infection in developed countries 
[53].Therefore these results are consistent with the results of other studies done outside 
Africa. 
  
9.2. Severe Malnutrition and Invasive NTS infection 
Two studies [5,11] have addressed the relationship between severe malnutrition and 
Invasive NTS infection. Berkley AJ et al [5] demonstrated that severe malnutrition is the 
risk factor for Invasive NTS infection. Malnutrition was among the commonest reason 
for admission among children with Invasive NTS infection. The odds of having Invasive 
NTS infection for children with severe malnutrition was 2.2 times higher than children 
without severe malnutrition. Brent AJ et al [11] also showed a positive association 
between severe malnutrition and Invasive NTS infection. In their study they showed that 
severe malnutrition is the risk factor for Invasive NTS disease OR 1.7(95%CI 1.2 -2.4) 
The nutritional requirements of the human body reflect the nutritional intake necessary 
to maintain optimal body function and to meet the body's daily energy needs. 
Malnutrition (literally, "bad nutrition") is defined as "inadequate nutrition," and while most 
people interpret this as under-nutrition, falling short of daily nutritional requirements, it 
can also mean over-nutrition, meaning intake in excess of what the body uses. 
However, under-nutrition affects more than one-third of the world's children, and nearly 
30 percent of people of all ages in the developing world, making this the most damaging 
form of malnutrition worldwide [54]. In fact, the relationship between malnutrition and 
infection is cyclical—infection predisposes one to malnutrition, and malnutrition, which 
impairs all immune defenses, predisposes one to infection. 
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9.3 Malaria/anemia and Invasive NTS infection 
One study [6] has shown an association between malaria and Invasive NTS infection. 
Enwere G et al [6] have shown that patients with malaria are more likely to succumb to 
Invasive NTS infection than those without malaria. In another study Brent AJ et al[11] 
have shown that three-fourths of invasive NTS patients with anemia had evidence of 
either current or recent malaria. It was not possible to know which proportions of anemia 
was infact due to malaria and therefore we can’t establish a temporal association 
between malaria and invasive NTS disease. Since malaria is a short term infection, 
prospective studies to ascertain temporal relationship are not feasible. 
The mechanism underlying the association between malaria and invasive NTS infection 
is partially understood. Hemolysis caused by Malaria parasites may impair macrophage 
and neutrophil function due to accumulation of malarial pigment by phagocytic cells, 
saturation of iron binding proteins and increased iron availability to NTS, a siderophilic 
organism. 
 
9.4 Recent antimicrobial use and Invasive NTS infection 
There was no African study that established recent antimicrobial use is a risk factor of 
Invasive NTS infection. There is however one evidence from USA study that has 
established that association. Pavia AT et al [35] have shown that people who have been 
treated with antibiotics frequently develop infections of Salmonella bacteria that have 
become resistant to antibiotics because they have survived previous antibiotic 
treatment. Another suggested mechanism of this association is due to the fact that 
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frequent antimicrobial use disrupts intestinal mucosa integrity thereby enhancing 
microbial penetration though gut mucosa. 
 
9.5 Age and Invasive NTS infection 
We have not been able to show a temporal association between age and acquisition of 
Invasive NTS infection. However one of the African study [29] in an attempt to develop 
vaccine against NTS showed that Healthy African adult serum did kill Salmonellae 
unlike serum from children under the age of 16 months, which often did not contain 
sufficient specific antibody titres to kill effectively. This suggests that infants are more 
likely to suffer from NTS infection than adults. Besides having underdeveloped immune 
system, infants have less achlorydia compared to adults. Older age may also be a risk 
factor of Invasive NTS infection due to impaired immunity. 
 
9.6 Schistosoma and Invasive NTS infection 
There was one study [42] which linked schistosomiasis and Invasive NTS infection. 
Gendrel et al showed that Schistosoma intercalatum has been demonstrated from rectal 
biopsy in 48 (91%) of 53 children with invasive NTS infection compared to 21 (38%) of 
55 in the control group (P <0.001), although only 28 of the controls had blood cultures 
performed. We can’t rely on this finding since only half of the controls have blood 
cultures performed. If all controls would have their blood cultures done and happen to 
have NTS, the results would be biased towards the null. 
 
9.7 Sickle cell and Invasive NTS infection 
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There was no study that demonstrates an association between sickle cell disease and 
Invasive NTS infection. There was one study [17] which showed that Salmonella 
accounts for 50% of the 36 organisms isolated from 32 sickle cell patients co infected 
with osteomyelitis. 
 
10. CONCLUSIONS AND FUTURE DIRECTIONS 
As Streptococcus pneumoniae and Haemophilus influenzae invasive disease are 
controlled by vaccine strategies, invasive Salmonella may consolidate its position as a 
leading cause of community-acquired bloodstream infection in sub-Saharan Africa. 
Despite the substantial burden of illness and death caused by invasive NTS disease, 
more research needs to be done to understand and control invasive NTS in sub-
Saharan Africa. Malaria, HIV and Severe Malnutrition have been associated with 
Invasive NTS infection. Since most of the febrile ill patients in Africa are diagnosed as 
having Malaria, it is crucial to improve our diagnostic technique and manage patients 
appropriately. This may involve increase in health expenditure by in country health 
ministries. Moreover, efforts directed to improve malaria control would be beneficial. 
Under-nutrition is the disease of the poor. Malnourished children are more likely to 
suffer from many infections than well nourished children. African Governments should 
make efforts to reduce poverty. This may be affected by combating corruption and 
explore employment opportunities. Research to determine the major environmental 
sources, modes of transmission, and to characterize risk factors for either mucosal 
colonization or infection and for invasive disease is urgently needed. It would be useful 
to understand more about the syndrome of invasive NTS in sub-Saharan Africa. 
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Specifically to analyze further proportion of persons with NTS diarrhea, or NTS carriers 
who develop invasive disease, pathogenesis, and the mortality of NTS bacteremia 
attributable to co-morbid conditions such as malnutrition, malaria, and HIV infection. 
Algorithms for the management of febrile illness need to be continually reevaluated to 
address the relative importance of malaria versus invasive bacterial infections such as 
NTS. Clinical effectiveness studies and surveillance for antimicrobial resistance and 
serotype distribution are needed to inform clinical management strategies, to detect 
changes in patterns of disease and to assist in vaccine development.  
 Improvement of diagnostic technique is crucial in order to prevent deaths associated 
with NTS bacteremia. Most importantly, clinical effectiveness studies and surveillance 
for antimicrobial resistance are needed in order to address clinical management 
strategies, to detect changes in the pattern of diseases and to assist in vaccine 
development. 
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Table 1.Classification of studies according to Oxford Evidence Based Medicine 
Levels of evidence (May 2001 version) 
STUDY TYPE EBM LEVEL 
Food and Water  
Milledge2005 and Kariuki 2006,Gordon 2008 2b 
Brent 2006 1b 
Wright 1986, Momba 2002 2c 
Clasen 2007 1c 
Mintz 1995 3a 
Schlundt 2004 3b 
  
Zoonotic and Anthroponotic transmission  
Morbidity Mortality Weekly Report 2007 4 
Kariuki 2006 2b 
Gordon2008, Nkuo2001, Paton 1991.  5 
  
Nosocomial Transmission  
Lepage 1990.Multiresistant Salmonella 4 
Paton 1991.Salmonella Gastroenteritis 5 
  
Risk factor studies  
Age  
Graham 2000, Berkley 2005, Enwere 2006, Sigauque 2009, 
Gordon 2008, Brent 2006, Walsh 2000. NTS bacteremia 
1b 
Cohen et al. 5 
  
Prior antimicrobial use  
Paton 1991l.Salmonella Gastroenteritis 5 
Pavia  1990.Antimicrobial exposure decrease resistance 3b 
  
Malaria and anemia  
Enwere 2006 and Mabey 1987 et al 3b 
Graham 2006, Bent 1b 
  
Malnutrition  
Berkley 2005 and Brent 2006 1b 
  
HIV  
Shaw 2008 ,Gordon 2008 and Berkley 2005 1b 
  
Gastric suppression  
Leonard 2007 3a 
Schistosomiasis and sickle cell disease  
Gendrel 1994  and Dowling 2002. 3b 
Ebong 1986 4 
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Figure 1.Literature review. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Citations identified by initial search 
N= 571 
Articles retrieved for in depth 
review N= 93 
Articles not matching criteria 
N= 478 
Articles meeting criteria N=15 
Articles from CDC 
library N= 17 
Articles reviewed from 
in depth review N= 11 
Articles not meeting criteria and 
excluded N= 89 
Articles associating risk factors and 
NTS 
N= 6 
Articles associating environment 
and NTS 
N= 9 
Articles not matching 
criteria N= 6 
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